Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …

Lupus nephritis remains one of the most severe manifestations of systemic lupus
erythematosus associated with considerable morbidity and mortality. A better understanding …

About one‐third of patients suffering from systemic lupus erythematosus have ocular
manifestations. The most common manifestation is keratoconjunctivitis sicca. The most …

Overlap Syndromes (OSs) have been defined as entities satisfying classification criteria of at
least two connective tissue diseases (CTDs) occurring at the same or at different times in the …

Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disease of
unknown etiology, whose hallmark is the production of autoantibodies. B cells are promising …

The steadily increasing knowledge regarding pathogenetic mechanisms in autoimmune
rheumatic diseases has paved the way to different therapeutic approaches. In particular, the …

Objective To analyse the efficacy and safety of rituximab in the treatment of non-renal
systemic lupus erythematosus (SLE). Methods We systematically searched MEDLINE …

Objective Conventional treatment of systemic lupus erythematosus (SLE) and lupus
nephritis (LN) is associated with damage accrual, hence increased morbidity rate. Off-label …

Refractory lupus nephritis indicates an inadequate response to lupus nephritis therapy. It
implies persisting or worsening disease activity despite therapy, but the definition is …

Background The neurological and psychiatric manifestations of systemic lupus
erythematosus (NPSLE) are a heterogeneous group of conditions with variable clinical …